Jennifer Sherak is an inspiring pharmaceutical and commercial executive with a proven track record of transforming organizations through strategic vision and innovative leadership. With expertise across pharmaceutical, biotech, wellness, and skincare industries, she is the founder and CEO of Sherak. Skin Renewal Chemistry, a science-driven skincare line designed for women over 40. Additionally, Jennifer serves on the Board of Directors for LiveWorld, a leading social-first digital agency and software company.
Previously, Jennifer was Senior Vice President and President of Specialty Physician Services at AmerisourceBergen (now Cencora), a Fortune 10 company, where she led the revitalization and multi-billion-dollar growth of a major business unit. Her leadership legacy extends beyond AmerisourceBergen with over 25 years of experience driving sales and marketing success in the pharmaceutical industry, particularly in oncology.
During her tenure at Takeda Pharmaceuticals, Jennifer spearheaded global commercialization strategies for oncology products and led business development efforts. Prior to this, she held pivotal roles at Shire Pharmaceuticals, overseeing the integration of Baxalta and broadening access to life-saving leukemia treatments. Her earlier career includes strategic positions at Baxalta, Biodesix, Celgene, Bristol Myers Squibb, and Novartis, where she led commercial strategy teams and managed product lifecycle planning on a global scale.
A passionate advocate for addressing unmet medical needs, Jennifer is equally dedicated to mentoring the next generation of leaders. She is committed to fostering both organizational growth and individual empowerment, helping others achieve their potential while building impactful businesses.
To learn more about Age Equity Alliance visit our LinkedIn page.
Connect with Jennifer through her LinkedIn page.
